title: Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease.
abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. PPARgamma regulates several metabolic pathways by binding to sequence-specific PPAR response elements in the promoter region of genes involved in lipid biosynthesis and glucose metabolism. However, more recently PPARgamma, PPARalpha and PPARbeta/delta agonists have been demonstrated to exhibit anti-inflammatory and immunomodulatory properties thus opening up new avenues for research. The actions of PPARgamma and PPARalpha activation are thought to be due to their ability to down regulate pro-inflammatory gene expression and inflammatory cell functions, and as such makes them an attractive target for novel drug intervention. Interestingly, PPARbeta/delta has been shown to be involved in wound healing, angiogenesis, lipid metabolism and thrombosis. In this review we will focus on the data describing the beneficial effects of these ligands in the airway and in the pulmonary vasculature and in vivo in animal models of allergic and occupational asthma, chronic obstructive pulmonary disease and pulmonary fibrosis. A clinical trial is underway to examine the effect of rosiglitazone in asthma patients and the outcome of this trial is awaited with much anticipation. In conclusion, PPARs are novel targets for lung disease and continued work with these ligands may result in a potential new treatment for chronic inflammatory lung diseases.
authors.affiliation: Respiratory Pharmacology Group, National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK. m.belvisi@imperial.ac.uk
authors.forename: Maria G
authors.initials: MG
authors.lastname: Belvisi
authors.forename: Jane A
authors.initials: JA
authors.lastname: Mitchell
mesh_terms: D001249:Asthma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000378:metabolism; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D047492:Peroxisome Proliferator-Activated Receptors
references.citation: J Biol Chem. 2002 Mar 1;277(9):6838-45
references.pmid: 11726654
references.citation: J Immunol. 2003 Mar 1;170(5):2663-9
references.pmid: 12594295
references.citation: Nature. 1996 Nov 7;384(6604):23-4
references.pmid: 8900268
references.citation: Br J Pharmacol. 2003 May;139(1):163-71
references.pmid: 12746235
references.citation: Int Arch Allergy Immunol. 2004 Jun;134 Suppl 1:30-6
references.pmid: 15166481
references.citation: Respir Res. 2007 Dec 04;8:90
references.pmid: 18053220
references.citation: Blood. 2004 Sep 1;104(5):1361-8
references.pmid: 15130939
references.citation: J Allergy Clin Immunol. 2004 May;113(5):882-8
references.pmid: 15131570
references.citation: Thorax. 2003 Sep;58(9):778-83
references.pmid: 12947137
references.citation: J Biol Chem. 2000 Sep 8;275(36):28028-32
references.pmid: 10827178
references.citation: Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):68-76
references.pmid: 17164134
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L891-901
references.pmid: 18162602
references.citation: Eur Respir J. 2005 Feb;25(2):225-34
references.pmid: 15684285
references.citation: J Biol Chem. 2000 Feb 18;275(7):4541-4
references.pmid: 10671476
references.citation: Mol Cell. 2007 Jan 12;25(1):57-70
references.pmid: 17218271
references.citation: Chest. 2008 Jul;134(1):152-7
references.pmid: 18628217
references.citation: Trends Pharmacol Sci. 2005 May;26(5):244-51
references.pmid: 15860371
references.citation: Circ Res. 2006 Feb 17;98(3):361-9
references.pmid: 16397146
references.citation: Am J Pathol. 2004 Jan;164(1):263-71
references.pmid: 14695339
references.citation: J Cell Biol. 2007 Feb 26;176(5):681-94
references.pmid: 17325208
references.citation: Cell. 1995 Dec 1;83(5):813-9
references.pmid: 8521498
references.citation: Endocr Rev. 1999 Oct;20(5):649-88
references.pmid: 10529898
references.citation: Science. 1988 May 13;240(4854):889-95
references.pmid: 3283939
references.citation: Mol Pharmacol. 2008 Feb;73(2):323-37
references.pmid: 17984196
references.citation: Antioxid Redox Signal. 2008 Feb;10(2):253-60
references.pmid: 17970647
references.citation: Lancet. 2005 Oct 8;366(9493):1279-89
references.pmid: 16214598
references.citation: Biochem Biophys Res Commun. 2001 May 4;283(2):344-6
references.pmid: 11327705
references.citation: Eur Respir J. 2007 Aug;30(2):245-52
references.pmid: 17459894
references.citation: Arch Biochem Biophys. 2003 Oct 15;418(2):186-96
references.pmid: 14522590
references.citation: Cell. 1998 Apr 17;93(2):241-52
references.pmid: 9568716
references.citation: PPAR Res. 2007;2007:71323
references.pmid: 17710235
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7614-9
references.pmid: 9636198
references.citation: Am J Respir Cell Mol Biol. 2006 Feb;34(2):242-6
references.pmid: 16239641
references.citation: J Immunol. 2003 May 15;170(10):5295-301
references.pmid: 12734379
references.citation: Endocrinology. 1996 Jan;137(1):354-66
references.pmid: 8536636
references.citation: J Biol Chem. 1998 Oct 2;273(40):25573-80
references.pmid: 9748221
references.citation: FEBS J. 2006 Jan;273(1):170-9
references.pmid: 16367757
references.citation: J Exp Med. 2003 Aug 4;198(3):411-21
references.pmid: 12900517
references.citation: N Engl J Med. 2004 Sep 9;351(11):1106-18
references.pmid: 15356308
references.citation: Am J Respir Cell Mol Biol. 2001 Jun;24(6):688-93
references.pmid: 11415933
references.citation: Am J Respir Cell Mol Biol. 2001 Jun;24(6):658-61
references.pmid: 11415929
references.citation: Nature. 1998 Jan 1;391(6662):79-82
references.pmid: 9422508
references.citation: Mol Endocrinol. 2007 Aug;21(8):1756-68
references.pmid: 17488971
references.citation: Lancet. 2002 Nov 2;360(9343):1410-8
references.pmid: 12424006
references.citation: Diabetes. 2000 Mar;49(3):346-55
references.pmid: 10868955
references.citation: J Biol Chem. 1983 Oct 10;258(19):11713-8
references.pmid: 6578214
references.citation: Respir Res. 2005 Aug 09;6:91
references.pmid: 16091136
references.citation: Eur J Pharmacol. 2006 Mar 8;533(1-3):101-9
references.pmid: 16458290
references.citation: Circ Res. 2003 May 30;92(10):1162-9
references.pmid: 12714563
references.citation: Am J Physiol Lung Cell Mol Physiol. 2006 Jul;291(1):L84-90
references.pmid: 16443643
references.citation: Trends Immunol. 2007 Dec;28(12):551-8
references.pmid: 17981503
references.citation: Shock. 2005 Dec;24(6):547-55
references.pmid: 16317386
references.citation: Expert Opin Ther Targets. 2004 Aug;8(4):265-85
references.pmid: 15268623
references.citation: Nature. 1998 Jan 1;391(6662):82-6
references.pmid: 9422509
references.citation: Eur Respir J. 2004 Jul;24(1):18-23
references.pmid: 15293600
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1146-53
references.pmid: 15734787
references.citation: J Biol Chem. 1999 Nov 5;274(45):32048-54
references.pmid: 10542237
references.citation: Science. 2003 Oct 17;302(5644):453-7
references.pmid: 12970571
references.citation: Cell. 1995 Dec 1;83(5):803-12
references.pmid: 8521497
references.citation: Exp Physiol. 2008 Jan;93(1):141-7
references.pmid: 17965142
references.citation: Curr Opin Cell Biol. 1998 Jun;10(3):384-91
references.pmid: 9640540
references.citation: J Med Chem. 2000 Feb 24;43(4):527-50
references.pmid: 10691680
references.citation: Pulm Pharmacol Ther. 2006;19(1):39-46
references.pmid: 16286236
references.citation: Hypertension. 2002 Nov;40(5):687-93
references.pmid: 12411463
references.citation: Gastroenterology. 2007 Jul;133(1):108-23
references.pmid: 17631136
references.citation: Endocrinology. 1996 Oct;137(10):4189-95
references.pmid: 8828476
references.citation: FASEB J. 2006 Feb;20(2):326-8
references.pmid: 16368717
references.citation: Clin Exp Allergy. 2006 Dec;36(12):1494-504
references.pmid: 17177672
references.citation: J Immunol. 2006 Oct 15;177(8):5248-57
references.pmid: 17015710
references.citation: Curr Opin Pharmacol. 2006 Jun;6(3):263-70
references.pmid: 16580256
references.citation: Proc Am Thorac Soc. 2006 Aug;3(6):510-1
references.pmid: 16921131
references.citation: Nature. 1999 Jul 22;400(6742):378-82
references.pmid: 10432118
references.citation: Clin Immunol. 2005 Feb;114(2):100-9
references.pmid: 15639643
references.citation: FEBS Lett. 2004 Aug 13;572(1-3):33-40
references.pmid: 15304320
references.citation: Eur J Pharmacol. 2003 Nov 28;481(2-3):261-9
references.pmid: 14642794
references.citation: Fundam Clin Pharmacol. 2006 Oct;20(5):429-47
references.pmid: 16968414
references.citation: Pharmacol Res. 2005 Feb;51(2):85-94
references.pmid: 15629253
references.citation: Inflamm Res. 2008 Jul;57(7):314-21
references.pmid: 18622687
references.citation: Nature. 1996 Nov 7;384(6604):39-43
references.pmid: 8900274
references.citation: Am J Respir Crit Care Med. 2004 Jan 15;169(2):195-200
references.pmid: 14563653
references.citation: Inflamm Res. 2005 Nov;54(11):464-70
references.pmid: 16307220
references.citation: Pharmacol Rev. 2006 Dec;58(4):726-41
references.pmid: 17132851
references.citation: Endocrinology. 1997 Sep;138(9):3695-703
references.pmid: 9275054